United States

Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH

The first targeted C3 therapy approved in the EU Approval based on results from head-to-head PEGASUS Phase 3 study where Aspaveli demonstrated superiority to eculizumab in improving hemoglobin levels1 Aspaveli will have market exclusivity for…

Read More »

OneWater Marine Enters into a Definitive Agreement to Acquire a Majority Interest in Quality Boats

Let’s Talk Interactive Names Daniel Boyce as Chief Product Officer

NRx Pharmaceuticals Added to the Nasdaq® Biotech Index

New Data Suggest COVAXIN™ (BBV152) Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination

KULR Receives Three-Year Multi-Million Dollar Battery Safety Deployment Order from Volta Energy Products

TransUnion Forecasts Originations to Non-Prime Borrowers Will Continue to Rise for Many Credit Products in 2022

Conn’s Announces Authorization of $150 Million Share Repurchase Program

TRI POINTE HOMES ANNOUNCES THE LAUNCH OF 55+ LIFESTYLE COMMUNITY BRAND, ALTIS

EVERYTHING BLOCKCHAIN FILES QUARTERLY FINANCIALS WITH SEC

AIM for Climate misses the mark and fails to support regenerative solutions and indigenous stewardship

Bionaut Labs and Candel Therapeutics Announce Strategic Collaboration in Precision-Targeted Delivery of Oncolytic Viral Immunotherapies

The Vault Brings Holiday Cheer to Unsung Car Scenes

Ambarella and Autobrains Collaborate on Scalable Range of AI Solutions From Front ADAS to Higher Levels of Autonomy for the Automotive Mass Market

Blue California Expands Natural Flavor and Fragrance Portfolio with Production of Clean, Natural, and Sustainable Nerolidol

Docker and Nuaware Team Up to Help the Channel Tap into Fast Growing Application Development Market

Rescale Appoints Frank Colich as Company’s First CFO and Mark Fieldhouse as General Manager of EMEA

Automotive Composites Market to cross US$ 6 Bn by 2027; Global Market Insights Inc.